The big business bet on psychedelic drugs
In the last few years, there has been an increase in research around using psychedelic drugs, like LSD and magic mushrooms, as treatments for mental health conditions. And recently, two Canadian companies working in the sphere have gotten a special designation from a big U.S. regulator that could fast-track the development and review of their drugs. Sean Silcoff is a journalist with The Globe’s Report on Business. He has been looking at recent developments in these companies and how that fits into the bigger picture of investor excitement around these drugs.
You May Also Like

700 WLW On-Demand
WLW-AM (WLWAM)

Israel Today: Ongoing War Report
Israel Today: Ongoing War Report

The Pete Quiñones Show
Peter R Quiñones

The Epstein Chronicles
Bobby Capucci

Le journal d'Europe 1
Europe 1

28 Minutes
ARTE Radio

SBS Arabic - أس بي أس عربي
SBS

Packernet Podcast: Daily Green Bay Packers Podcast
AC Sports

Bloomberg News Now
Bloomberg

Brian Kilmeade Show
FOX News Podcasts
Community discussion